Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic crossroads in metabolic and cardiovascular health: the role of DNA methylation in type 2 diabetes and cardiovascular diseases.

Cardiovascular diabetology - 29 May 2025

Kaimala Suneesh, Yassin Lidya K, Hamad Mohammad I K, Allouh Mohammed Z, Sampath Prabha, AlKaabi Juma, Leow Melvin Khee-Shing, Shehab Safa, Ansari Suraiya Anjum, Emerald Bright Starling

Abstract excerpt

Type 2 diabetes (T2D) and cardiovascular diseases (CVD), part of the metabolic syndrome (MetS), are major contributors to the global health crisis today. A recent report from the World Health Organisation estimates that 17.9 million lives are lost each year to CVD, and one-third of these are premature. The international diabetes federation estimates that around 537 million adults aged between 20 and 79 years are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Energy Metabolism

Share to Epigenesis, Genetic

Share to Metabolic Syndrome

Share to Prognosis

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 40442704
DOI: 10.1186/s12933-025-02800-x
PMCID: PMC12124063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic crossroads in metabolic and cardiovascular health: the role of DNA methylation in type 2 diabetes and cardiovascular diseases.PMID 40442704Read ↗

Oxidative Stress and DNA Methylation Regulation in the Metabolic SyndromeSemantic proximity Read ↗

Novel insights into DNA methylation and its critical implications in diabetic vascular complicationsSemantic proximity Read ↗

Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implicationsSemantic proximity Read ↗

Epigenetics Plays a Role in the Pathogenesis and Treatment of DiabetesSemantic proximity Read ↗

DNA Methylation: An Epigenetic Insight into Type 2 Diabetes MellitusSemantic proximity Read ↗

DNA methylation in obesity and type 2 diabetesSemantic proximity Read ↗

Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic FrontiersSemantic proximity Read ↗

Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets.Semantic proximity Read ↗

DNA methylation and its role in the pathogenesis of diabetesSemantic proximity Read ↗

The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.Semantic proximity Read ↗

Epigenomic biomarkers of cardiometabolic disease: How far are we from daily practice?Semantic proximity Read ↗

Epigenetic mechanisms in cardiovascular complications of diabetes: towards future therapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.